Jeongho Kim PhD , Tae Gyu Kim MD , Byungdo Park PhD , Hyunjung Kim MD , Yun Gyu Song MD , Hyoun Wook Lee MD , Young Zoon Kim MD , Jun Ho Ji MD , Seok-Hyun Kim MD , Sung Min Kim MD , Jun Ho Lee MD , Haeyoung Kim MD
{"title":"Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boost","authors":"Jeongho Kim PhD , Tae Gyu Kim MD , Byungdo Park PhD , Hyunjung Kim MD , Yun Gyu Song MD , Hyoun Wook Lee MD , Young Zoon Kim MD , Jun Ho Ji MD , Seok-Hyun Kim MD , Sung Min Kim MD , Jun Ho Lee MD , Haeyoung Kim MD","doi":"10.1016/j.meddos.2023.08.007","DOIUrl":null,"url":null,"abstract":"<div><p><span>The HyperArc technique is known for generating high-quality radiosurgical treatment plans for intracranial lesions or hippocampal-sparing whole-brain </span>radiotherapy<span><span> (WBRT). However, there is no reported feasibility of using the HyperArc technique in hippocampal-sparing WBRT with a simultaneous integrated boost (SIB). This study aimed to compare dosimetric parameters of 2 commercially-available volumetric-modulated arc radiotherapy techniques, HyperArc and </span>RapidArc<span>, when using hippocampal-sparing WBRT with a SIB to treat brain metastases.</span></span></p><p><span>Treatment plans using HyperArc and RapidArc techniques were generated retrospectively for 19 previously treated patients (1 to 3 brain metastases). The planning target volumes for the whole brain (excluding the hippocampal avoidance region; PTV</span><sub>WB</sub><span>) and metastases (PTV</span><sub>met</sub>) were prescribed 25 and 45 Gy, respectively, in 10 fractions. Each plan included homogeneous and inhomogeneous delivery to the PTV<sub>met</sub>. Dosimetric parameters for the target (conformity index [CI], homogeneity index [HI], target coverage [D<sub>95%</sub>]), and nontarget organs at risk were compared for the HyperArc and RapidArc plans.</p><p>For homogeneous delivery, dosimetric parameters, including mean CI, HI, and target coverage in PTV<sub>WB</sub> and PTV<sub>met</sub>, were superior for HyperArc than RapidArc plans (all <em>p</em> < 0.01). The PTV<sub>WB</sub> and PTV<sub>met</sub> target coverage for HyperArc plans was significantly greater than for RapidArc plans (96.17% <em>vs</em> 93.38%, <em>p</em> < 0.01; 94.02% <em>vs</em> 92.21%, <em>p</em> < 0.01, respectively). HyperArc plans had significantly lower mean hippocampal D<sub>max</sub> and D<sub>min</sub> values than RapidArc plans (D<sub>max</sub>: 15.53 Gy <em>vs</em>, 16.71 Gy, <em>p</em> < 0.01; D<sub>min</sub>: 8.33 Gy <em>vs</em> 8.93 Gy, <em>p</em> < 0.01, respectively). Similarly, inhomogeneous delivery of hyperArc produced a superior target and lower hippocampal dosimetric parameters than RapidArc, except for the HI of PTV<sub>met</sub> (all <em>p</em> < 0.01).</p><p>HyperArc generated superior conformity and target coverage with lower hippocampal doses than RapidArc. HyperArc could be an attractive technique for hippocampal-sparing WBRT with an SIB.</p></div>","PeriodicalId":49837,"journal":{"name":"Medical Dosimetry","volume":"49 2","pages":"Pages 69-76"},"PeriodicalIF":1.1000,"publicationDate":"2023-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Dosimetry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0958394723000729","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The HyperArc technique is known for generating high-quality radiosurgical treatment plans for intracranial lesions or hippocampal-sparing whole-brain radiotherapy (WBRT). However, there is no reported feasibility of using the HyperArc technique in hippocampal-sparing WBRT with a simultaneous integrated boost (SIB). This study aimed to compare dosimetric parameters of 2 commercially-available volumetric-modulated arc radiotherapy techniques, HyperArc and RapidArc, when using hippocampal-sparing WBRT with a SIB to treat brain metastases.
Treatment plans using HyperArc and RapidArc techniques were generated retrospectively for 19 previously treated patients (1 to 3 brain metastases). The planning target volumes for the whole brain (excluding the hippocampal avoidance region; PTVWB) and metastases (PTVmet) were prescribed 25 and 45 Gy, respectively, in 10 fractions. Each plan included homogeneous and inhomogeneous delivery to the PTVmet. Dosimetric parameters for the target (conformity index [CI], homogeneity index [HI], target coverage [D95%]), and nontarget organs at risk were compared for the HyperArc and RapidArc plans.
For homogeneous delivery, dosimetric parameters, including mean CI, HI, and target coverage in PTVWB and PTVmet, were superior for HyperArc than RapidArc plans (all p < 0.01). The PTVWB and PTVmet target coverage for HyperArc plans was significantly greater than for RapidArc plans (96.17% vs 93.38%, p < 0.01; 94.02% vs 92.21%, p < 0.01, respectively). HyperArc plans had significantly lower mean hippocampal Dmax and Dmin values than RapidArc plans (Dmax: 15.53 Gy vs, 16.71 Gy, p < 0.01; Dmin: 8.33 Gy vs 8.93 Gy, p < 0.01, respectively). Similarly, inhomogeneous delivery of hyperArc produced a superior target and lower hippocampal dosimetric parameters than RapidArc, except for the HI of PTVmet (all p < 0.01).
HyperArc generated superior conformity and target coverage with lower hippocampal doses than RapidArc. HyperArc could be an attractive technique for hippocampal-sparing WBRT with an SIB.
期刊介绍：
Medical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
